The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients.

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The ECLA PHRI COLCOVID Trial is a simple, pragmatic randomized open controlled trial to test the effects of colchicine on moderate/high-risk hospitalized COVID-19 patients with the aim of reducing mortality and/or new requirement for mechanical ventilation.
Epistemonikos ID: ae5fb1023a4543dfb7aa2c6523c588c92fd8bf8b
First added on: Mar 31, 2020